CAS: 2375482-51-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BI-2852 REF: IN-DA01K4U9CAS: 2375482-51-0 | 98% | To inquire | Tue 07 Jan 25 |
 | BI-2852 REF: 3D-AVD48251CAS: 2375482-51-0 | Min. 95% | To inquire | Tue 18 Feb 25 |
 | BI-2852 REF: TM-T10533CAS: 2375482-51-0 | 98.98% | 115.00 €~1,263.00 € | Tue 25 Feb 25 |
Ref: IN-DA01K4U9
| 1mg | 225.00 € | ||
| 5mg | 531.00 € | ||
| 10mg | 554.00 € | ||
| 25mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
BI-2852
CAS:2375482-51-0
BI-2852 is a drug binding inhibitor that is selective for the protein kinases of the …
Formula:
C31H28N6O2
Purity:
Min. 95%
Molecular weight:
516.6 g/mol
Ref: 3D-AVD48251
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
BI-2852
CAS:2375482-51-0
BI-2852: nanomolar affinity KRAS switch I/II pocket inhibitor; blocks signaling, halts KRAS mutant cell growth.
Formula:
C31H28N6O2
Purity:
98.98%
Color and Shape:
Solid
Molecular weight:
516.59
Ref: TM-T10533
| 1mg | 115.00 € | ||
| 5mg | 271.00 € | ||
| 10mg | 401.00 € | ||
| 25mg | 664.00 € | ||
| 50mg | 916.00 € | ||
| 100mg | 1,263.00 € | ||
| 1mL*10mM (DMSO) | 312.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
